RenovoRx - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi RNXT

Tandha merek renovorx.com (RNXT)

Export control risks for high-tech software create a certain vulnerability for RenovoRx, Inc. (RNXT). The company's total operating profit on this chart demonstrates current liquidity, while 0.00 determines the current status of the parameter. Stable laboratory operations guarantee system scaling, and profitability is based on the implementation of targeted chemotherapy technologies for specialized hospitals and oncological surgeons.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi RenovoRx, Inc. (RNXT): kanggo periode 23.11.2025 - 13.11.2026

RenovoRx (RNXT) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Bagan bursa RenovoRx Corporation|RNXT - Target konsensus
- rincian nilai pasar emiten:
Nilai pasar RenovoRx|RNXT - Nilai Total Perusahaan
- statistik nilai buku emiten:
Nilai Aset Bersih saben Saham RenovoRx|RNXT - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih renovorx.com|RNXT - Total Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal RenovoRx, Inc.|RNXT - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas RenovoRx Inc|RNXT - Gunggung utang perusahaan|Rasio utang marang aset resik RenovoRx|RNXT - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan RenovoRx|Likuiditas darurat renovorx.com
- rincian bathi lan kelipatan pasar:
RNXT - Bathi resik perusahaan|Prakiraan bathi resik RenovoRx, Inc.|RNXT - Rasio rega marang bathi|Rasio prakiraan rega marang bathi renovorx.com|RNXT - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan RenovoRx|RNXT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan RenovoRx|RNXT - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan renovorx.com|RNXT - Wutah bathi resik saben saham ing taun iki|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep RenovoRx, Inc.
Ringkesan analitik perusahaan:RenovoRx Corporation
Produk asli RenovoRx Corp

This indicator measures daily operating cash flow, excluding the impact of the tax burden and debt service costs to assess the real efficiency of the business. Analyzing the EBITDA history allows an investor to correlate returns with volatility, which is critical for RenovoRx, Inc. (RNXT), as the development costs for the RenovoTAMP platform determine the company's financial stability during the clinical trial phase.

Pesaing RenovoRx, Inc. (RNXT)

Pendapatan operasional sadurunge ngurangi amortisasi TriSalus Corp (TLSI)|PMCB: Bathi operasional sadurunge ngurangi amortisasi